| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2022 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLUTTER ENTMT PLC | 1 | Q2 2024 | 8.4% |
| CRH PLC | 1 | Q2 2024 | 6.6% |
| STELLANTIS N.V | 1 | Q2 2024 | 6.5% |
| MICROSOFT CORP | 1 | Q2 2024 | 4.8% |
| NVIDIA CORPORATION | 1 | Q2 2024 | 4.4% |
| VISA INC | 1 | Q2 2024 | 3.9% |
| META PLATFORMS INC | 1 | Q2 2024 | 3.8% |
| FERRARI N V | 1 | Q2 2024 | 3.5% |
| TAIWAN SEMICONDUCTOR MFG LTD | 1 | Q2 2024 | 2.4% |
| LINDE PLC | 1 | Q2 2024 | 2.4% |
View DNCA FINANCE's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Evelo Biosciences, Inc. | February 21, 2023 | 5 | 5.0% |
| BioXcel Therapeutics, Inc. | March 06, 2020 | 892,453 | 4.4% |
View DNCA FINANCE's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-07-30 |
| 13F-HR | 2024-07-15 |
| SC 13D/A | 2023-02-21 |
| SC 13D/A | 2022-11-21 |
| SC 13D/A | 2022-08-23 |
| SC 13D | 2021-12-28 |
| SC 13D/A | 2020-03-06 |
| SC 13D/A | 2020-02-24 |
| SC 13D/A | 2020-02-18 |
| SC 13D | 2018-09-14 |
View DNCA FINANCE's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.